ATNM · CIK 0001388320 · FY2025 live · 2025-12-31
Actinium Pharmaceuticals, Inc.
View as
Model
Classic Z
FY2025
−12.32
Zone
Distress
Prior
—
Market DD
—
1y PD
—
−12.32
Z″ −25.07
Score −12.32 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.801.2 × = 0.96X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−7.911.4 × = −11.08X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−0.703.3 × = −2.31X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
0.180.6 × = 0.11X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.001 × = 0.00
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
Actinium Pharmaceuticals, Inc. is on classic Z at −12.32 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 13th percentile in Healthcare.
- BOLTDistressBolt Biotherapeutics, Inc.−12.34
- PDSBDistressPDS Biotechnology Corp−12.36
- MODDDistressModular Medical, Inc.−12.19
- MREODistressMereo BioPharma Group plc−12.17
- RCELDistressAVITA Medical, Inc.−12.07
- CUEDistressCue Biopharma, Inc.−11.97
- IXHLDistressIncannex Healthcare Inc.−12.73
- HOWLDistressWerewolf Therapeutics, Inc.−11.75
KPI widgets
Current assets
$49M
Total assets
$52M
Current liabilities
$8M
Total liabilities
$44M
Working capital
$41M
Retained earnings
−$410M
EBIT
−$36M
Total sales
$90K
Book equity
$8M
Accession 0001213900-26-036504. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 12 Sept 2026.